NNT-20232-46841
4 vaccinations
4 coded responses
26 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 379 / TN
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-22
Survey response — day 7, dose 2MedDRA: Pyrexia — Feeling: GoodFree text: Had a fever the night after I received the vaccine, none by the next morningMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-02-03
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-11-19
Dose 3 — Pfizer-BioNTech
-
2022-01-12
Survey response — 12 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, HospitalizationFree text: Gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
- 2022-01-13
- 2022-05-20
-
2022-11-05
Dose 4 — Pfizer-BioNTech
-
2022-11-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-11-07
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-12
- 2022-11-20
-
2022-11-28
Survey response — day 21, dose 4MedDRA: Influenza, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold/flu symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-03
Survey response — day 28, dose 4MedDRA: Gastroenteritis viral — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach bugMedDRA releases: 2024-11 · check-in free text available
- 2022-12-10
- 2022-12-17
- 2023-02-06
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
| 4 | 2022-11-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — day 7, dose 2
Systemic reaction (other): Had a fever the night after I received the vaccine, none by the next morning
Release 10 — 12 months, dose 2
Symptoms: Gave birth
Release 12 — day 21, dose 4
Symptoms: Cold/flu symptoms
Release 12 — day 28, dose 4
Symptoms: Stomach bug
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release